Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Renowel
Renowel (Erythropoietin Prefilled Syringe Injection) is a recombinant erythropoietin therapy designed to treat anemia by stimulating red blood cell production in the bone marrow. It is essential for managing anemia in chronic kidney disease and chemotherapy patients.
Uses of Renowel
Treatment of anemia associated with chronic kidney disease (CKD).
Management of chemotherapy-induced anemia in cancer patients.
Used in certain hematological disorders, including myelodysplastic syndromes.
Reduces the need for blood transfusions in anemic patients.
Benefits of Renowel
Effectively increases hemoglobin levels and improves oxygen transport.
Reduces dependency on blood transfusions.
Enhances energy levels and overall quality of life in anemic patients.
Supports erythropoiesis with controlled dosing for optimal therapeutic outcomes.
Mechanism of Action of Renowel
Erythropoietin binds to erythroid progenitor cells in the bone marrow, promoting their differentiation and proliferation into mature red blood cells. This increases hemoglobin production, improving oxygen-carrying capacity and reducing symptoms of anemia.